题名

An Aspergilloma Switched to a Chronic Necrotizing Pulmonary Aspergillosis in a Patient with Pulmonary Tuberculosis and Pneumoconiosis History

并列篇名

麴菌腫塊轉變成慢性壞死性肺部麴菌感染發生在一個有過肺結核及塵肺症的病人

作者

陳宗家(Tsung-Chia Chen);何茂旺(Mao-Wang Ho)

关键词

慢性壞死性肺部麴菌感染 ; 肺結核 ; 麴菌腫塊 ; Chronic necrotizing pulmonary aspergillosis ; Pulmonary tuberculosis ; Aspergilloma

期刊名称

醫學與健康期刊

卷期/出版年月

5卷2期(2016 / 09 / 01)

页次

119 - 125

内容语文

英文

中文摘要

肺結核是台灣常見的一種疾病。許多的病人會留下肺部開洞性病變。在這些開洞的病人中有一部分人會在開洞中形成麴菌腫塊進一步發展成慢性壞死性肺部麴菌感染。在此我們將報導一位有肺結核及塵肺症病史的病人慢慢發展成慢性壞死性肺部麴菌感染的病例並做一些文獻回顧。

英文摘要

Pulmonary tuberculosis is an endemic disease in Taiwan, and its frequent sequela is cavitation. Some of these patients subsequently develop into chronic pulmonary aspergillosis (CPA). We herein report a case of chronic necrotizing pulmonary aspergillosis, which occurred gradually in a patient with aspergilloma, who also had pulmonary tuberculosis and pneumoconiosis history.

主题分类 醫藥衛生 > 預防保健與衛生學
醫藥衛生 > 社會醫學
参考文献
  1. Denning, DW,Pleuvry, A,Cole, DC(2011).Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis.Bull World Health Organ,89,864-72.
  2. Lass-Flörl, C,Roilides, E,Löffler, J,Wilflingseder, D,Romani, L(2013).Minireview: host defence in invasive asper-gillosis.Mycoses,56,403-13.
  3. Nakamota, K,Takayanagi, N,Kanauchi, T,Ishiguro, T,Yanagisawa, T,Sugita, Y(2013).Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis.Intern Med,52,727-34.
  4. Ohba, H,Miwa, S,Shirai, M(2012).Clinical characteristics and prognosis of chronic pulmonary aspergillosis.Respir Med,106,724-9.
  5. Prasad, R,Garg, SR(2009).Progressive increase in cavitation with the evolution of fungal ball: A clue to the diagnosis of chronic necrotizing pulmonary aspergillosis.Lung India,26,95-7.
  6. Saito, T,Fugiuchi, S,Tao, Y(2012).Efficacy and safety of voriconazole in the treatment of chronic pulmonary asper-gillosis: experience in Japan.Infection,40,661-7.
  7. Tsubura, E(1997).Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma. Pulmonary Aspergilloma Study Group.Kekkaku,72,557-64.
  8. Walsh, TJ,Anaissie, EJ,Denning, DW(2008).Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.Clin Infect Dis,46,327-60.
  9. Warris, A(2014).The biology of pulmonary aspergillus infections.J Infect,69(Suppl 1),S36-41.
  10. Wu, CJ,Lee, HC,Lo, HJ,Ko, WC(2011).Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis.Diagn Microbiol Infect Dis,70,528-30.